Skip to main content
Equibles
SNNC logo

SNNC · Sibannac, Inc.

Track SNNC — free

Use SNNC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SNNC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.00 +0.00 (+2.17%) At close · Nov 11
Rebalance outlook locked
Market Cap
$82,378
Shares
17.53M
Volume · Nov 11 114K Avg daily vol (3M) 396.32K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.00 Open$0.00 Day$0.00–0.00 52W close$0.00–0.02 Avg vol 30d341K Short int145K · 0.8% of shares · 1.0d Short vol21% DataFeb 2020–Nov 2026

Latest documents

2020
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
−$213,447
Trailing 12 months
Net income (TTM)
−$263,756
Trailing 12 months
Revenue growth YoY
-99.9%
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.0%
Year over year
Price change (1Y)
-66.4%
Trailing year
Short interest
—
Latest settlement
View all 125 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Neutral Momentum Weak Sentiment Bearish Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 18.7 · elevated Equity put/call 0.72
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −45%
below
Price vs 50-day avg −2%
below
RSI (14) 50
neutral
MACD trend Positive
52-week position 7%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return +9%
trailing
6-month return −64%
trailing
YTD return −62%
this year
Relative strength −66%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.83% of shares out · ▲ +15.3% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 331%
annualized · 1-yr
Max drawdown −85%
past year
ATR 23.4%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
2 · 4 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−45% Bearish
Price vs 50-day avg
−2% Neutral
RSI (14)
50 Neutral
MACD trend
Positive Bullish
52-week position
7% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross) No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.83% of shares out · ▲ +15.3% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0 Now $0 · 7% Range high $0
vs 200-day avg -45% vs 50-day avg -2%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Drug Manufacturers - Specialty & Generic — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
SNNC
Sibannac, Inc.
this stock
$82,378 -62.1% — — 0.8%
TAK
Takeda Pharmaceutical Co Ltd
 $67.48B +35.5% — — 0.1%
GALDY
Galderma Group AG
 $54.01B +11.7% — — 0.0%
TEVA
Teva Pharmaceutical Industries Ltd
 $50.93B +39.9% +4.3% 99.2 2.4%
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
 $40.66B — — — 0.1%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest Rising
Shares short
145.2K
Days to cover
1.0d
Change
+19.2K sh
View
Short Volume
Short vol %
21%
As of
Nov 11, 2026
Short Total
View
Fails to Deliver
FTD shares
2.7K
Value
$55
As of
Sep 9, 2025
View
Off-Exchange
Off-exchange %
100.0%
Week of
Oct 5, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$0
Net income (FY)
$-351.0K
View
Filings
SEC Filings
Latest
8-K
Filed
Jul 21, 2020
This year
0
View

Performance

5D 20D 120D MTD YTD
SNNC +6.8% +9.3% -63.9% -6.0% -62.1%
SPY -0.9% -1.3% +2.3% +0.5% +11.4%
vs SPY +7.7% +10.6% -66.2% -6.5% -73.5%
Key facts CIK 1313938 Visit website Investor relations